Jeffrey S. Heier, Chief Scientific Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 21,004 shares at $11.04 ($232K) on 2025-10-02, disclosed to the SEC on 2025-10-06.
Scheduled sale ($232k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.04 | 10,502 | $116K | 50.0% |
| 2 | $11.04 | 10,502 | $116K | 50.0% |
| Total | $11.04 avg | 21,004 | $232K | 100% |
| Filing → |
| OCUL | SELL | 2026-05-28 | $25K | — | Filing → |
| OCUL | SELL | 2026-02-25 | $25K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $42K | — | Filing → |